$BMY Recent News
Market rookie Five Prime's shares surge on deal with Bristol-Myers 12:01 p.m. March 17, 2014 - Russ Britt
RadioShack sinks; J.C. Penney gains on S&P outlook hike 5:19 p.m. March 4, 2014 - Sue Chang
Bristol-Myers plans late-stage tests on Yervoy as lung-cancer treatment 5:01 p.m. March 4, 2014 - Russ Britt
Billionaire Stan Druckenmiller's recent moves 12:50 p.m. Feb. 24, 2014 - Insider Monkey
Feds, pharma rivals team up on Alzheimer's 3:32 p.m. Feb. 6, 2014 - Elizabeth O'Brien
Merck hits a new high as analyst sees opening for new cancer drug 12:16 p.m. Jan. 27, 2014 - Russ Britt
U.S. stocks tumble; Dow drops 318 points 6:29 p.m. Jan. 24, 2014 - Anora Mahmudova
Juniper buoyed by Jana stake; Herbalife loss grows 4:50 p.m. Jan. 24, 2014 - Sue Chang
U.S. stock futures trim losses ahead of market open 9:57 a.m. Jan. 24, 2014 - Barbara Kollmeyer
Beam, Honeywell, Procter & Gamble are stocks to watch 6:38 a.m. Jan. 24, 2014 - Sue Chang
AstraZeneca, Bristol-Myers Secure EU OK for Xigduo 3:44 a.m. Jan. 22, 2014 - MarketWatch.com
‘Sloppy’ market turns to consumer, tech earnings 9:01 a.m. Jan. 19, 2014 - Wallace Witkowski
America's best and most generous 401(k)s 3:30 p.m. Jan. 15, 2014 - Anne Tergesen
Merck initiates melanoma filing with FDA 12:45 p.m. Jan. 13, 2014 - Tess Stynes
Statin usefulness questioned, but patent expirations may ease pain 2:02 p.m. Jan. 8, 2014 - Russ Britt
Not all pharmaceuticals are created equal 1:40 p.m. Dec. 26, 2013 - The Trading Deck
FTSE 100 rises, shaking off retail data after Fed taper 1:06 p.m. Dec. 19, 2013 - Sara Sjolin
European stocks rally on Fed taper, rate views 1:00 p.m. Dec. 19, 2013 - Sara Sjolin
AstraZeneca to buy Bristol-Myers diabetes-JV stake 4:25 a.m. Dec. 19, 2013 - MarketWatch.com
Pfizer and Kaiser: They not only rhyme, they're in sync with workers 12:12 p.m. Dec. 10, 2013 - Russ Britt
Bristol-Myers Squibb Company (BMY): Today's Featured Drugs Laggard 5:01 p.m. Today - TheStreet.com
Gilead's HCV Challengers Near The Starting Gate 4:28 p.m. March 19, 2014 - Investors Business Daily
Veteran Investor's Top Biotech and Drug Stocks 7:57 a.m. March 19, 2014 - Barrons.com
Gilead's HCV Challengers Near The Starting Gate 7:02 a.m. March 19, 2014 - Investors Business Daily
Cramer's Mad Money - Profits, Not Putin (3/18/14) 6:18 a.m. March 19, 2014 - Seeking Alpha
Jim Cramer's 'Mad Money' Recap: Profits Still Matter 8:07 p.m. March 18, 2014 - TheStreet.com
Bristol-Myers, Five Prime In Cancer Pact 9:35 a.m. March 17, 2014 - The Wall Street Journal Interactive Edition
Bristol-Myers and Five Prime ink collaboration 7:28 a.m. March 17, 2014 - Seeking Alpha
Jim Cramer's 'Mad Money' Recap: Next Week's Game Plan 8:24 p.m. March 14, 2014 - TheStreet.com
Bristol-Myers and Pfizer Win Approval of New Indication for Eliquis 5:28 p.m. March 14, 2014 - Wall St. Cheat Sheet
Big Pharma drug clears regulatory hurdle 1:52 p.m. March 14, 2014 - Seeking Alpha
Insider Trading Alert - UNM, SEM And BMY Traded By Insiders 12:30 p.m. March 14, 2014 - TheStreet.com
BMY May 2nd Options Begin Trading 11:56 a.m. March 13, 2014 - TheStreet.com
Pfizer Breast-Cancer Drug To Show If It's For Real 4:51 p.m. March 10, 2014 - Investors Business Daily
3 Stocks Reiterated As A Buy: BMY, CAT, AXP 3:28 p.m. March 10, 2014 - TheStreet.com
On the hunt with the "pharmaceutical scouts" 10:00 a.m. March 10, 2014 - Seeking Alpha
Four Upcoming Catalysts That Could Move Pharmaceutical Stocks 8:19 a.m. March 10, 2014 - 247WallSt.com
Pharmaceutical Scouts Chase Hot Prospects 10:38 p.m. March 9, 2014 - The Wall Street Journal Interactive Edition
Biotech Stock Mailbag: Exact Sciences, Rexahn, Advaxis, Peregrine 10:49 a.m. March 7, 2014 - TheStreet.com
Total Dividend Return Will Guide My 2014 Investment Decisions 9:59 p.m. March 6, 2014 - Seeking Alpha
Trace One Names Mark Martini as Vice President of North America to Lead Sales and Customer Development 9:01 a.m. Today - BusinessWire - BZX
Portola Pharmaceuticals Initiates Phase 3 Study of Andexanet Alfa, Potential First-in-Class Factor Xa Inhibitor Reversal Agent, Under Accelerated Approval Pathway 8:15 a.m. March 19, 2014 - GlobeNewswire
Health Care Stocks Review -- Research on Bristol-Myers Squibb, Johnson & Johnson, Merck & Co. and Eli Lilly 8:00 a.m. March 19, 2014 - PR Newswire - PRF
Five Prime Therapeutics and Bristol-Myers Squibb Sign Collaboration Agreement to Discover Novel Immuno-Oncology Therapies for Two Immune Checkpoint Pathways 6:59 a.m. March 17, 2014 - BusinessWire - BZX
Five Prime Therapeutics and Bristol-Myers Squibb Sign Collaboration Agreement to Discover Novel Immuno-Oncology Therapies for Two Immune Checkpoint Pathways 6:59 a.m. March 17, 2014 - GlobeNewswire
U.S. FDA Approves Eliquis® (apixaban) To Reduce The Risk Of Blood Clots Following Hip Or Knee Replacement Surgery 1:00 p.m. March 14, 2014 - BusinessWire - BZX
Investment Grants, Data Presentations, Clinical Study Results, and Collaborative Programs - Analyst Notes on UnitedHealth Group, Bristol-Myers Squibb, AbbVie, Cigna, and OXiGENE 8:00 a.m. March 14, 2014 - PR Newswire - PRF
Pharma-Biotech Industry Helps Drive $14.4 Billion Industrial Project Activity in Massachusetts, an Industrial Info News Alert 6:30 a.m. March 10, 2014 - Marketwire
Medivir: SVR12 Results from a Phase IIa Study Evaluating Simeprevir and Daclatasvir in Hepatitis C Patients of Genotype 1 Have Been Presented 12:30 p.m. March 4, 2014 - BusinessWire - BZX
Bristol-Myers Squibb Announces Dividend 4:30 p.m. March 3, 2014 - BusinessWire - BZX
LUNGevity Foundation Receives Major Grant for Education Initiative 1:53 p.m. March 3, 2014 - PR Newswire - PRF
Bristol-Myers Squibb Announces Charitable Donation of $1 Million to Support Immuno-Oncology Education for Patients and Caregivers 7:30 a.m. March 3, 2014 - BusinessWire - BZX
Mead Johnson Nutrition Expands Board and Appoints Michael Grobstein as Director 10:15 a.m. Feb. 28, 2014 - BusinessWire - BZX
Aethlon Medical Expands Clinical Network Through DaVita Agreement 3:01 p.m. Feb. 26, 2014 - ACCESSWIRE
U.S. FDA approves orphan drug MyaleptTM (metreleptin for injection) 2:05 p.m. Feb. 25, 2014 - BusinessWire - BZX
Bristol-Myers Squibb Receives U.S. FDA Breakthrough Therapy Designation for All-Oral Daclatasvir Dual Investigational Regimen for Chronic Hepatitis C 8:30 a.m. Feb. 24, 2014 - BusinessWire - BZX
In a Subanalysis, Eliquis® (apixaban) Reduced the Risk of Stroke and Demonstrated Fewer Major Bleeding Events versus Warfarin Consistently across Age Groups, Including Older Patients with Nonvalvular Atrial Fibrillation 11:06 a.m. Feb. 21, 2014 - BusinessWire - BZX
Bristol-Myers Squibb to Present at Cowen and Company 34th Annual Global Health Care Conference 2:00 p.m. Feb. 20, 2014 - BusinessWire - BZX
Bristol-Myers Squibb to Present at Citi 2014 Global Health Care Conference 3:30 p.m. Feb. 14, 2014 - BusinessWire - BZX
Galectin Therapeutics Leaps Ahead with SBH Sciences Partnership 11:02 a.m. Feb. 13, 2014 - ACCESSWIRE
Market rookie Five Prime's shares surge on deal with Bristol-Myers 12:01 p.m. March 17, 2014 - Russ Britt
RadioShack sinks; J.C. Penney gains on S&P outlook hike 5:19 p.m. March 4, 2014 - Sue Chang
Bristol-Myers plans late-stage tests on Yervoy as lung-cancer treatment 5:01 p.m. March 4, 2014 - Russ Britt
Billionaire Stan Druckenmiller's recent moves 12:50 p.m. Feb. 24, 2014 - Insider Monkey
Feds, pharma rivals team up on Alzheimer's 3:32 p.m. Feb. 6, 2014 - Elizabeth O'Brien
Merck hits a new high as analyst sees opening for new cancer drug 12:16 p.m. Jan. 27, 2014 - Russ Britt
U.S. stocks tumble; Dow drops 318 points 6:29 p.m. Jan. 24, 2014 - Anora Mahmudova
Juniper buoyed by Jana stake; Herbalife loss grows 4:50 p.m. Jan. 24, 2014 - Sue Chang
U.S. stock futures trim losses ahead of market open 9:57 a.m. Jan. 24, 2014 - Barbara Kollmeyer
Beam, Honeywell, Procter & Gamble are stocks to watch 6:38 a.m. Jan. 24, 2014 - Sue Chang
AstraZeneca, Bristol-Myers Secure EU OK for Xigduo 3:44 a.m. Jan. 22, 2014 - MarketWatch.com
‘Sloppy’ market turns to consumer, tech earnings 9:01 a.m. Jan. 19, 2014 - Wallace Witkowski
America's best and most generous 401(k)s 3:30 p.m. Jan. 15, 2014 - Anne Tergesen
Merck initiates melanoma filing with FDA 12:45 p.m. Jan. 13, 2014 - Tess Stynes
Statin usefulness questioned, but patent expirations may ease pain 2:02 p.m. Jan. 8, 2014 - Russ Britt
Not all pharmaceuticals are created equal 1:40 p.m. Dec. 26, 2013 - The Trading Deck
FTSE 100 rises, shaking off retail data after Fed taper 1:06 p.m. Dec. 19, 2013 - Sara Sjolin
European stocks rally on Fed taper, rate views 1:00 p.m. Dec. 19, 2013 - Sara Sjolin
AstraZeneca to buy Bristol-Myers diabetes-JV stake 4:25 a.m. Dec. 19, 2013 - MarketWatch.com
Pfizer and Kaiser: They not only rhyme, they're in sync with workers 12:12 p.m. Dec. 10, 2013 - Russ Britt
Bristol-Myers Squibb Company (BMY): Today's Featured Drugs Laggard 5:01 p.m. Today - TheStreet.com
Gilead's HCV Challengers Near The Starting Gate 4:28 p.m. March 19, 2014 - Investors Business Daily
Veteran Investor's Top Biotech and Drug Stocks 7:57 a.m. March 19, 2014 - Barrons.com
Gilead's HCV Challengers Near The Starting Gate 7:02 a.m. March 19, 2014 - Investors Business Daily
Cramer's Mad Money - Profits, Not Putin (3/18/14) 6:18 a.m. March 19, 2014 - Seeking Alpha
Jim Cramer's 'Mad Money' Recap: Profits Still Matter 8:07 p.m. March 18, 2014 - TheStreet.com
Bristol-Myers, Five Prime In Cancer Pact 9:35 a.m. March 17, 2014 - The Wall Street Journal Interactive Edition
Bristol-Myers and Five Prime ink collaboration 7:28 a.m. March 17, 2014 - Seeking Alpha
Jim Cramer's 'Mad Money' Recap: Next Week's Game Plan 8:24 p.m. March 14, 2014 - TheStreet.com
Bristol-Myers and Pfizer Win Approval of New Indication for Eliquis 5:28 p.m. March 14, 2014 - Wall St. Cheat Sheet
Big Pharma drug clears regulatory hurdle 1:52 p.m. March 14, 2014 - Seeking Alpha
Insider Trading Alert - UNM, SEM And BMY Traded By Insiders 12:30 p.m. March 14, 2014 - TheStreet.com
BMY May 2nd Options Begin Trading 11:56 a.m. March 13, 2014 - TheStreet.com
Pfizer Breast-Cancer Drug To Show If It's For Real 4:51 p.m. March 10, 2014 - Investors Business Daily
3 Stocks Reiterated As A Buy: BMY, CAT, AXP 3:28 p.m. March 10, 2014 - TheStreet.com
On the hunt with the "pharmaceutical scouts" 10:00 a.m. March 10, 2014 - Seeking Alpha
Four Upcoming Catalysts That Could Move Pharmaceutical Stocks 8:19 a.m. March 10, 2014 - 247WallSt.com
Pharmaceutical Scouts Chase Hot Prospects 10:38 p.m. March 9, 2014 - The Wall Street Journal Interactive Edition
Biotech Stock Mailbag: Exact Sciences, Rexahn, Advaxis, Peregrine 10:49 a.m. March 7, 2014 - TheStreet.com
Total Dividend Return Will Guide My 2014 Investment Decisions 9:59 p.m. March 6, 2014 - Seeking Alpha
Trace One Names Mark Martini as Vice President of North America to Lead Sales and Customer Development 9:01 a.m. Today - BusinessWire - BZX
Portola Pharmaceuticals Initiates Phase 3 Study of Andexanet Alfa, Potential First-in-Class Factor Xa Inhibitor Reversal Agent, Under Accelerated Approval Pathway 8:15 a.m. March 19, 2014 - GlobeNewswire
Health Care Stocks Review -- Research on Bristol-Myers Squibb, Johnson & Johnson, Merck & Co. and Eli Lilly 8:00 a.m. March 19, 2014 - PR Newswire - PRF
Five Prime Therapeutics and Bristol-Myers Squibb Sign Collaboration Agreement to Discover Novel Immuno-Oncology Therapies for Two Immune Checkpoint Pathways 6:59 a.m. March 17, 2014 - BusinessWire - BZX
Five Prime Therapeutics and Bristol-Myers Squibb Sign Collaboration Agreement to Discover Novel Immuno-Oncology Therapies for Two Immune Checkpoint Pathways 6:59 a.m. March 17, 2014 - GlobeNewswire
U.S. FDA Approves Eliquis® (apixaban) To Reduce The Risk Of Blood Clots Following Hip Or Knee Replacement Surgery 1:00 p.m. March 14, 2014 - BusinessWire - BZX
Investment Grants, Data Presentations, Clinical Study Results, and Collaborative Programs - Analyst Notes on UnitedHealth Group, Bristol-Myers Squibb, AbbVie, Cigna, and OXiGENE 8:00 a.m. March 14, 2014 - PR Newswire - PRF
Pharma-Biotech Industry Helps Drive $14.4 Billion Industrial Project Activity in Massachusetts, an Industrial Info News Alert 6:30 a.m. March 10, 2014 - Marketwire
Medivir: SVR12 Results from a Phase IIa Study Evaluating Simeprevir and Daclatasvir in Hepatitis C Patients of Genotype 1 Have Been Presented 12:30 p.m. March 4, 2014 - BusinessWire - BZX
Bristol-Myers Squibb Announces Dividend 4:30 p.m. March 3, 2014 - BusinessWire - BZX
LUNGevity Foundation Receives Major Grant for Education Initiative 1:53 p.m. March 3, 2014 - PR Newswire - PRF
Bristol-Myers Squibb Announces Charitable Donation of $1 Million to Support Immuno-Oncology Education for Patients and Caregivers 7:30 a.m. March 3, 2014 - BusinessWire - BZX
Mead Johnson Nutrition Expands Board and Appoints Michael Grobstein as Director 10:15 a.m. Feb. 28, 2014 - BusinessWire - BZX
Aethlon Medical Expands Clinical Network Through DaVita Agreement 3:01 p.m. Feb. 26, 2014 - ACCESSWIRE
U.S. FDA approves orphan drug MyaleptTM (metreleptin for injection) 2:05 p.m. Feb. 25, 2014 - BusinessWire - BZX
Bristol-Myers Squibb Receives U.S. FDA Breakthrough Therapy Designation for All-Oral Daclatasvir Dual Investigational Regimen for Chronic Hepatitis C 8:30 a.m. Feb. 24, 2014 - BusinessWire - BZX
In a Subanalysis, Eliquis® (apixaban) Reduced the Risk of Stroke and Demonstrated Fewer Major Bleeding Events versus Warfarin Consistently across Age Groups, Including Older Patients with Nonvalvular Atrial Fibrillation 11:06 a.m. Feb. 21, 2014 - BusinessWire - BZX
Bristol-Myers Squibb to Present at Cowen and Company 34th Annual Global Health Care Conference 2:00 p.m. Feb. 20, 2014 - BusinessWire - BZX
Bristol-Myers Squibb to Present at Citi 2014 Global Health Care Conference 3:30 p.m. Feb. 14, 2014 - BusinessWire - BZX
Galectin Therapeutics Leaps Ahead with SBH Sciences Partnership 11:02 a.m. Feb. 13, 2014 - ACCESSWIRE
